News for Healthier Living

AI-Based Liquid Biopsy May Detect Liver Fibrosis, Cirrhosis and Chronic Disease Signals

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat landscapes can detect early liver fibrosis and cirrhosis, and may also reveal signals of broader chronic disease burden.

March 4, 2026


March 4 2026

March 3 2026

March 2 2026

March 1 2026

February 28 2026

February 27 2026

February 26 2026

February 25 2026

February 24 2026

February 23 2026

February 22 2026

February 21 2026

February 20 2026

February 19 2026